Document ID: chunk:federal_register_of_legislation:F2025L00049:schedule:4:p16
Version: federal_register_of_legislation:F2025L00049
Segment Type: schedule
Provision Reference: sch 4 (pt 16/22)
Character Range: 229741–233267

each containing more than 1000 mg paracetamol; or
 (f) in tablets or capsules enclosed in a primary pack containing more than 100 tablets or capsules except in Schedule 3; or
 (g) in individually wrapped powders or sachets of granules enclosed in a primary pack containing more than 50 wrapped powders or sachets of granules except when included in Schedule 3; or
 (h) for injection; or
 (i) for the treatment of animals.
PARALDEHYDE.
PARAMETHADIONE.
PARAMETHASONE.
PARECOXIB.
PARICALCITOL.
PARITAPREVIR.
PAROMOMYCIN.
PAROXETINE.
PASIREOTIDE.
PATIROMER SORBITEX CALCIUM.
PATISIRAN.
PAZOPANIB.
PECAZINE.
PEFLOXACIN.
PEGAPTANIB.
PEGASPARGASE.
PEGCETACOPLAN.
PEGFILGRASTIM.
PEGINTERFERON.
PEGVALIASE.
PEGVISOMANT.
PEMBROLIZUMAB.
PEMETREXED.
PEMIGATINIB.
PEMOLINE.
PEMPIDINE.
PENBUTOLOL.
PENCICLOVIR except in preparations containing 1% or less of penciclovir for the treatment of herpes labialis in packs containing 10 g or less.
PENETHAMATE.
PENICILLAMINE.
PENTAERYTHRITYL TETRANITRATE.
PENTAGASTRIN.
PENTAMETHONIUM.
PENTAMIDINE (includes pentamidine isetionate).
PENTHIENATE.
# PENTOBARBITAL when packed and labelled for injection.
PENTOLINIUM.
PENTOSAN POLYSULFATE SODIUM.
PENTOXIFYLLINE.
PERAMIVIR.
# PERAMPANEL.
PERGOLIDE.
PERHEXILINE.
PERICIAZINE.
PERINDOPRIL.
PERMETHRIN for human therapeutic use except in preparations containing 5% or less of permethrin.
PERPHENAZINE.
PERTUSSIS ANTIGEN.
PERTUZUMAB.
PHENACEMIDE.
PHENACETIN for therapeutic use (excluding when present as an excipient).
PHENAGLYCODOL.
PHENAZONE except when included in Schedule 2 or 5.
PHENAZOPYRIDINE.
PHENELZINE.
PHENETICILLIN.
PHENFORMIN.
PHENGLUTARIMIDE.
PHENINDIONE.
PHENIRAMINE except when included in Schedule 2 or 3.
PHENISATIN.
PHENOBARBITAL.
PHENOL in preparations for injection.
PHENOLPHTHALEIN for human therapeutic use.
PHENOXYBENZAMINE.
PHENOXYMETHYLPENICILLIN.
PHENSUXIMIDE.
# PHENTERMINE.
PHENTHIMENTONIUM.
PHENTOLAMINE.
PHENYLBUTAZONE.
PHENYLEPHRINE:
 (a) in preparations for injection; or
 (b) in preparations for human ophthalmic use containing 5% or more of phenylephrine.
PHENYLPIRACETAM.
PHENYLPROPANOLAMINE.
PHENYLTOLOXAMINE.
PHENYTOIN.
PHLEUM PRATENSE POLLEN EXTRACT (Timothy‑grass pollen extract).
PHOLCODINE:
 (a) in divided preparations containing 100 mg or less of pholcodine per dosage unit; or
 (b) in undivided preparations containing 2.5% or less of pholcodine;
           except when included in Schedule 2.
PHOSPHODIESTERASE TYPE 5 INHIBITORS except:
 (a) when separately specified in these Schedules; or
 (b) when present as an unmodified, naturally occurring substance.
PHTHALYLSULFATHIAZOLE.
PHYSOSTIGMINE.
PIBRENTASVIR.
PICROTOXIN.
PILOCARPINE except in preparations containing 0.025% or less of pilocarpine.
PIMECROLIMUS.
PIMOBENDAN.
PIMOZIDE.
PINACIDIL.
PINAVERIUM BROMIDE.
PINDOLOL.
PIOGLITAZONE.
PIPECURONIUM.
PIPEMIDIC ACID.
PIPENZOLATE.
PIPER METHYSTICUM (kava) in preparations for human use except when included on the Register in preparations:
 (a) for oral use when present in tablet, capsule or teabag form that is labelled with a recommended maximum daily dose of 250 mg or less of kavalactones and:

          (i) the tablet or capsule form contains 125 mg or less of kavalactones per tablet or capsule; or

          (ii) the amount of dried whole or peeled rhizome and/or root in the teabag does not exceed 3 g;
  and, where containing more than 25 mg of kavalactones per dose, compliant with the requirements of the required advisory statements for medicine labels; or
 (b) in topical preparations for